Slug/β-catenin-dependent proinflammatory phenotype in hypoxic breast cancer stem cells

American Journal of Pathology

Volumn 183, Issue 5, 2013, Pages 1688-1697

  Storci, Gianluca ^a,b   Bertoni, Sara ^b   De Carolis, Sabrina ^a,b   Papi, Alessio ^c   Nati, Marina ^a   Ceccarelli, Claudio ^a   Pirazzini, Chiara ^a   Garagnani, Paolo ^a   Ferrarini, Alberto ^c   Buson, Genny ^c   Delledonne, Massimo ^c   Fiorentino, Michelangelo ^b   Capizzi, Elisa ^b   Gruppioni, Elisa ^b   Taffurelli, Mario ^a   Santini, Donatella ^a   Franceschi, Claudio ^a   Bandini, Giuseppe ^b   Bonifazi, Francesca ^b   Bonafé, Massimiliano ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; ESTROGEN RECEPTOR ALPHA; HISTONE H2AX; INTERLEUKIN 8; MESSENGER RNA; MICRORNA 221; RAD51 PROTEIN; TRANSCRIPTION FACTOR SLUG; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE MARROW; BREAST CANCER; CANCER GROWTH; CANCER STEM CELL; CONTROLLED STUDY; CYTOPLASM; DNA DAMAGE; FEMALE; HISTONE PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA STABILITY; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

AUTOCRINE COMMUNICATION; BETA CATENIN; BREAST NEOPLASMS; CELL HYPOXIA; CYTOKINES; DNA DAMAGE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; INFLAMMATION; MCF-7 CELLS; MESENCHYMAL STROMAL CELLS; MODELS, BIOLOGICAL; NEOPLASTIC STEM CELLS; PHENOTYPE; RAD51 RECOMBINASE; RNA, MESSENGER; SERINE; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84886703878     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.07.020     Document Type: Article

References (50)

1. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke Prospective identification of tumorigenic breast cancer cells Proc Natl Acad Sci U S A 100 2003 3983 3988
2. M.Y. Konopleva, and C.T. Jordan Leukemia stem cells and microenvironment: biology and therapeutic targeting J Clin Oncol 29 2011 591 599
3. A. Papi, G. Storci, T. Guarnieri, S. De Carolis, S. Bertoni, N. Avenia, A. Sanguinetti, A. Sidoni, D. Santini, C. Ceccarelli, M. Taffurelli, M. Orlandi, and M. Bonafé Peroxisome proliferator activated receptor-α/hypoxia inducible factor-1α interplay sustains carbonic anhydrase IX and apolipoprotein E expression in breast cancer stem cells PLoS One 8 2013 e54968
4. V. Rajasekhar, L. Studer, W. Gerald, N.D. Socci, and H.I. Scher Tumor-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signaling Nat Commun 2 2011 162
5. H. Korkaya, S. Liu, and M.S. Wicha Breast cancer stem cells, cytokine networks, and the tumor microenvironment J Clin Invest 121 2011 3804 3809
6. P. Sansone, G. Storci, S. Tavolari, T. Guarnieri, C. Giovannini, M. Taffurelli, C. Ceccarelli, D. Santini, P. Paterini, K.B. Marcu, P. Chieco, and M. Bonafè IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland J Clin Invest 117 2007 3988 4002
7. G. Storci, P. Sansone, S. Mari, G. D'Uva, S. Tavolari, T. Guarnieri, M. Taffurelli, C. Ceccarelli, D. Santini, P. Chieco, K.B. Marcu, and M. Bonafè TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype J Cell Physiol 225 2010 682 691
8. H. Korkaya, G.I. Kim, A. Davis, F. Malik, N.L. Henry, S. Ithimakin, A.A. Quraishi, N. Tawakkol, R. D'Angelo, A.K. Paulson, S. Chung, T. Luther, H.J. Paholak, S. Liu, K.A. Hassan, Q. Zen, S.G. Clouthier, and M.S. Wicha Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population Mol Cell 47 2012 570 584
9. S. Prasad, J. Ravindran, and B.B. Aggarwal NF-kappaB and cancer: how intimate is this relationship Mol Cell Biochem 336 2010 25 37
10. K.E. Lee, and M.C. Simon From stem cells to cancer stem cells: HIF takes the stage Curr Opin Cell Biol 24 2012 232 235
11. H. Harrison, L. Rogerson, H.J. Gregson, K.R. Brennan, R.B. Clarke, and G. Landberg Contrasting hypoxic effects on breast cancer stem cell hierarchy is dependent on ER- A status Cancer Res 73 2013 1420 1433
12. G.L. Semenza Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy Trends Pharmacol Sci 33 2012 207 214
13. S. Seidel, B.K. Garvalov, V. Wirta, L. von Stechow, A. Schänzer, K. Meletis, M. Wolter, D. Sommerlad, A.T. Henze, M. Nistér, G. Reifenberger, J. Lundeberg, J. Frisén, and T. Acker A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha Brain 133 2010 983 995
14. A.D. Hartkopf, M. Banys, N. Krawczyk, A. Staebler, S. Becker, J. Hoffmann, M. Hahn, M. Wallwiener, and T. Fehm Bone marrow versus sentinel lymph node involvement in breast cancer: a comparison of early hematogenous and early lymphatic tumor spread Breast Cancer Res Treat 131 2012 501 508
15. J.P. Lévesque, F.M. Helwani, and I.G. Winkler The endosteal 'osteoblastic' niche and its role in hematopoietic stem cell homing and mobilization Leukemia 24 2010 1979 1992
16. R.S. Bindra, and P.M. Glazer Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia Oncogene 26 2007 2048 2057
17. C.J. Chang, J.Y. Yang, W. Xia, C.T. Chen, X. Xie, C.H. Chao, W.A. Woodward, J.M. Hsu, G.N. Hortobagyi, and M.C. Hung EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling Cancer Cell 19 2011 86 100
18. S. Liu, C. Ginestier, E. Charafe-Jauffret, H. Foco, C.G. Kleer, S.D. Merajver, G. Dontu, and M.S. Wicha BRCA1 regulates human mammary stem/progenitor cell fate Proc Natl Acad Sci U S A 105 2008 1680 1685
19. F. Rodier, J.P. Coppé, C.K. Patil, W.A. Hoeijmakers, D.P. Muñoz, S.R. Raza, A. Freund, E. Campeau, A.R. Davalos, and J. Campisi Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion Nat Cell Biol 11 2009 973 979
20. K.W. McCool, and S. Miyamoto DNA damage-dependent NF-κB activation: NEMO turns nuclear signaling inside out Immunol Rev 246 2012 311 326
21. J. Niu, Y. Shi, G. Tan, C.H. Yang, M. Fan, L.M. Pfeffer, and Z.H. Wu DNA damage induces NF-κB-dependent microRNA-221 up-regulation and promotes breast cancer cell invasion J Biol Chem 287 2012 21783 21795
22. C. Scheel, E.N. Eaton, S.H. Li, C.L. Chaffer, F. Reinhardt, K.J. Kah, G. Bell, W. Guo, J. Rubin, A.L. Richardson, and R.A. Weinberg Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast Cell 145 2011 926 940
23. P. Bhat-Nakshatri, H. Appaiah, C. Ballas, P. Pick-Franke, R. Goulet Jr., S. Badve, E.F. Srour, and H. Nakshatri SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype BMC Cancer 10 2010 411
24. G. Storci, P. Sansone, D. Trere, S. Tavolari, M. Taffurelli, C. Ceccarelli, T. Guarnieri, P. Paterini, M. Pariali, L. Montanaro, D. Santini, P. Chieco, and M. Bonafé The basal-like breast carcinoma phenotype is regulated by SLUG gene expression J Pathol 214 2008 25 37
25. M. Pérez-Caro, C. Bermejo-Rodríguez, I. González-Herrero, M. Sánchez-Beato, M.A. Piris, and I. Sánchez-García Transcriptomal profiling of the cellular response to DNA damage mediated by Slug (Snai2) Br J Cancer 98 2008 480 488
26. T. Ikuta, and K. Kawajiri Zinc finger transcription factor Slug is a novel target gene of aryl hydrocarbon receptor Exp Cell Res 312 2006 3585 3594
27. T.A. Proia, P.J. Keller, P.B. Gupta, I. Klebba, A.D. Jones, M. Sedic, H. Gilmore, N. Tung, S.P. Naber, S. Schnitt, E.S. Lander, and C. Kuperwasser Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate Cell Stem Cell 8 2011 149 163
28. W. Guo, Z. Keckesova, J.L. Donaher, T. Shibue, V. Tischler, F. Reinhardt, S. Itzkovitz, A. Noske, U. Zürrer-Härdi, G. Bell, W.L. Tam, S.A. Mani, A. van Oudenaarden, and R.A. Weinberg Slug and Sox9 cooperatively determine the mammary stem cell state Cell 148 2012 1015 1028
29. E.P. Rogakou, D.R. Pilch, A.H. Orr, V.S. Ivanova, and W.M. Bonner DNA double stranded breaks induce histone H2AX phosphorylation on serine 139 J Biol Chem 273 1998 5858 5868
30. H. Korkaya, A. Paulson, E. Charafe-Jauffret, C. Ginestier, M. Brown, J. Dutcher, S.G. Clouthier, and M.S. Wicha Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling PLoS Biol 7 2009 e1000121
31. I. Kim, H. Kwak, H.K. Lee, S. Hyun, and S. Jeong β-Catenin recognizes a specific RNA motif in the cyclooxygenase-2 mRNA 3′-UTR and interacts with HuR in colon cancer cells Nucleic Acids Res 40 2012 6863 6872
32. S. Galardi, N. Mercatelli, M.G. Farace, and S.A. Ciafrè NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells Nucleic Acids Res 39 2011 3892 3902
33. S. Stinson, M.R. Lackner, A.T. Adai, N. Yu, H.J. Kim, C. O'Brien, J. Spoerke, S. Jhunjhunwala, Z. Boyd, T. Januario, R.J. Newman, P. Yue, R. Bourgon, Z. Modrusan, H.M. Stern, S. Warming, F.J. de Sauvage, L. Amler, R.F. Yeh, and D. Dornan miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer Sci Signal 4 186 2011 pt5
34. L. Krejci, V. Altmannova, M. Spirek, and X. Zhao Homologous recombination and its regulation Nucleic Acids Res 40 2012 5795 5818
35. S.A. Tenenbaum, P.J. Lager, C.C. Carson, and J.D. Keene Ribonomics: identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays Methods 26 2002 191 198
36. M. Heinonen, A. Hemmes, K. Salmenkivi, K. Abdelmohsen, S.T. Vilén, M. Laakso, M. Leidenius, T. Salo, S. Hautaniemi, M. Gorospe, P. Heikkilä, C. Haglund, and A. Ristimäki Role of RNA binding protein HuR in ductal carcinoma in situ of the breast J Pathol 224 2011 529 539
37. E. Lambertini, A. Lolli, F. Vezzali, L. Penolazzi, R. Gambari, and R. Piva Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells BMC Cancer 12 2012 445
38. X. Rao, G. Di Leva, M. Li, F. Fang, C. Devlin, C. Hartman-Frey, M.E. Burow, M. Ivan, C.M. Croce, and K.P. Nephew MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways Oncogene 30 2011 1082 1097
39. M.K. Asiedu, J.N. Ingle, M.D. Behrens, D.C. Radisky, and K.L. Knutson TGFbeta/TNFalpha-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype Cancer Res 71 2011 4707 4719
40. X. Yin, C.C. Wolford, Y.S. Chang, S.J. McConoughey, S.A. Ramsey, A. Aderem, and T. Hai ATF3, an adaptive-response gene, enhances TGF{beta} signaling and cancer-initiating cell features in breast cancer cells J Cell Sci 123 2010 3558 3565
41. M. Andäng, J. Hjerling-Leffler, A. Moliner, T.K. Lundgren, G. Castelo-Branco, E. Nanou, E. Pozas, V. Bryja, S. Halliez, H. Nishimaru, J. Wilbertz, E. Arenas, M. Koltzenburg, P. Charnay, A. El Manira, C.F. Ibañez, and P. Ernfors H2AX-dependent GABA(A) receptor regulation of stem cell proliferation Nature 451 2008 460 464
42. M. Economopoulou, H.F. Langer, A. Celeste, V.V. Orlova, E.Y. Choi, M. Ma, A. Vassilopoulos, E. Callen, C. Deng, C.H. Bassing, M. Boehm, A. Nussenzweig, and T. Chavakis Histone H2AX is integral to hypoxia-driven neovascularization Nat Med 15 2009 553 558
43. M. Gorospe, K. Tominaga, X. Wu, M. Fahling, and M. Ivan Post-transcriptional control of the hypoxic response by RNA-binding proteins and microRNAs Front Mol Neurosci 4 2011 7
44. M. Anson, A.M. Crain-Denoyelle, V. Baud, F. Chereau, A. Gougelet, B. Terris, S. Yamagoe, S. Colnot, M. Viguier, C. Perret, and J.P. Couty Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice J Clin Invest 122 2012 586 599
45. Z.Q. Wu, X.Y. Li, C.Y. Hu, M. Ford, C.G. Kleer, and S.J. Weiss Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression Proc Natl Acad Sci U S A 109 2012 16654 16659
46. S.T. Lee, Z. Li, Z. Wu, M. Aau, P. Guan, R.K. Karuturi, Y.C. Liou, and Q. Yu Context-specific regulation of NF-κB target gene expression by EZH2 in breast cancers Mol Cell 43 2011 798 810
47. F. Penault-Llorca, and G. Viale Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective Ann Oncol 6 2012 vi19-22
48. R. Scully, J. Chen, R.L. Ochs, K. Keegan, M. Hoekstra, J. Feunteun, and D.M. Livingston Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage Cell 90 1997 425 435
49. A. Nagelkerke, S.J. Van Kuijk, F.C. Sweep, I.D. Nagtegaal, N. Hoogerbrugge, J.W. Martens, M.A. Timmermans, H.W. van Laarhoven, J. Bussink, and P.N. Span Constitutive expression of γ-H2AX has prognostic relevance in triple negative breast cancer Radiother Oncol 101 2011 39 45
50. R. Barbano, M. Copetti, G. Perrone, V. Pazienza, L.A. Muscarella, T. Balsamo, C.T. Storlazzi, M. Ripoli, M. Rinaldi, V.M. Valori, T.P. Latiano, E. Maiello, P. Stanziale, M. Carella, A. Mangia, F. Pellegrini, M. Bisceglia, A.O. Muda, V. Altomare, R. Murgo, V.M. Fazio, and P. Parrella High RAD51 mRNA expression characterize estrogen receptor-positive/progesterone receptor-negative breast cancer and is associated with patient's outcome Int J Cancer 129 2011 536 545